 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 08/03/2026 |
$9.00 |
$9.08 |
$8.77 |
$8.81 |
3.19M | | 08/04/2026 |
$8.82 |
$9.04 |
$8.76 |
$9.02 |
2.92M | | 08/05/2026 |
$9.44 |
$9.67 |
$8.81 |
$9.07 |
6.09M | | 08/06/2026 |
$9.04 |
$9.53 |
$8.98 |
$9.30 |
4.04M | | 08/07/2026 |
$9.50 |
$9.67 |
$9.23 |
$9.38 |
4.38M |
 |
| BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. Co. leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of hereditary angioedema (HAE) attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the U.S.. Its other products and product candidates include BCX10013, RAPIACTA (peramivir injection), PERAMIFLU (peramivir injection), and early-stage discovery programs. | |
 |

BioCryst Pharmaceuticals (BCRX) has the following price history information. Looking back at BCRX historical stock prices for the last five trading days, on August 03, 2026, BCRX opened at $9.00, traded as high as $9.08 and as low as $8.77, and closed at $8.81. Trading volume was a total of 3.19M shares. On August 04, 2026, BCRX opened at $8.82, traded as high as $9.04 and as low as $8.76, and closed at $9.02. Trading volume was a total of 2.92M shares. On August 05, 2026, BCRX opened at $9.44, traded as high as $9.67 and as low as $8.81, and closed at $9.07. Trading volume was a total of 6.09M shares. On August 06, 2026, BCRX opened at $9.04, traded as high as $9.53 and as low as $8.98, and closed at $9.30. Trading volume was a total of 4.04M shares. On August 07, 2026, BCRX opened at $9.50, traded as high as $9.67 and as low as $9.23, and closed at $9.38. Trading volume was a total of 4.38M shares.
BCRX Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into BioCryst Pharmaceuticals shares, starting with a $10,000 purchase of BCRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
08/10/2016 |
|
| End date: |
08/07/2026 |
|
| Start price/share: |
$5.00 |
|
| End price/share: |
$9.38 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
87.60% |
|
| Average Annual Total Return: |
6.50% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$18,768.14 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 08/03/2026 | $8.81 | | 08/04/2026 | $9.02 | | 08/05/2026 | $9.07 | | 08/06/2026 | $9.30 | | 08/07/2026 | $9.38 |
|
 |